Search results
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly...
CW39 NewsFix· 6 days agoSobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for ...
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 3 days agoMoreover, this financial metric is significantly higher than that of its key competitors, such as Eli Lilly (NYSE:LLY), Sanofi (NASDAQ:SNY) and Roche...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 12 hours agoUSA News Group – An alarming trend is happening around the world, where tens of millions of...
Red Book Atlas of Pediatric Infectious Diseases, 5th Edition [eBook] | AAP
American Academy of Pediatrics· 21 hours agoDr Tan is Professor of Pediatrics at the Feinberg School of Medicine, Northwestern University, and a Pediatric Infectious Diseases attending; Medical Director of the International Patient and ...
Puerto Rico declares an epidemic after dengue cases spike. What you need to know.
The Day· 6 days agoOn Monday, government leaders in Puerto Rico declared a dengue epidemic after a spike in cases of the mosquito-borne disease hit the island. From the start of the year through March 10, there ...
Antibiotics Market to Reach $68.22 Billion By 2030 fueled by Rising Antimicrobial Resistance and...
Digital Journal· 3 days agoThe global antibiotics market size is valued at USD 49.51 billion in 2022 and is expected to reach...
UPDATED: Bristol Myers cutting $1.5B in costs in less than 2 years, with 2,200 employees impacted in...
FierceBiotech· 7 days agoBristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025, including laying off more than 2,000 employees. The ...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks· 21 hours agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales for the full year.
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024) | JD Supra
JD Supra· 7 days agoThe Federal Circuit handed down an opinion last week that invalidated several asserted claims and found infringement under 35 U.S.C. § 271(e)(2) of the claims, while refusing to modify its judgment ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoGlobal Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight PR Newswire LAS VEGAS, April 25, 2024 The increasing occurrence of kidney disorders worldwide and the healthcare sector's increased focus
